ARYx Therapeutics, Inc.
ARYX · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $36 | $55 | $19 |
| Short-Term Investments | $0 | $9 | $8 | $32 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $2 | $1 |
| Total Curr. Assets | $9 | $46 | $65 | $51 |
| Property Plant & Equip (Net) | $2 | $3 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $2 | $1 | $1 |
| Total NC Assets | $4 | $5 | $5 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $12 | $51 | $70 | $57 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $1 |
| Short-Term Debt | $5 | $4 | $4 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $5 | $4 | $4 |
| Other Curr. Liab. | $3 | $5 | $5 | $4 |
| Total Curr. Liab. | $9 | $11 | $13 | $12 |
| LT Debt | $7 | $13 | $3 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $17 | $132 |
| Total NC Liab. | $7 | $13 | $21 | $139 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $0 | $0 |
| Total Liabilities | $15 | $24 | $34 | $150 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$187 | -$154 | -$123 | -$95 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $184 | $181 | $158 | $1 |
| Total Equity | -$3 | $27 | $35 | -$94 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $12 | $51 | $70 | $57 |
| Net Debt | $4 | -$20 | -$48 | -$9 |